Evidence map›Paper›PMID 24395786›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation.

Angelo Vozza, Giovanni Parisi, Francesco De Leonardis, Francesco M Lasorsa, Alessandra Castegna, Daniela Amorese, Raffaele Marmo, Valeria M Calcagnile, Luigi Palmieri, Daniel Ricquier and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 243 papers.

0numbers the graph read from it
0cells of the map it votes in
243citing papers in PubMed
21.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

243 citing papers in PubMed, 398 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. From the cytosol to the inner membrane: biogenesis of the mitochondrial carrier family.Protein science : a publication of the Protein Society · 2026
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

183 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Angelo VozzaDepartment of Biosciences, Biotechnologies, and Biopharmaceutics and Center of Excellence in Comparative Genomics, University of Bari, 70125 Bari, Italy.
Giovanni Parisi
Francesco De Leonardis
Francesco M Lasorsa
Alessandra Castegna
Daniela Amorese
Raffaele Marmo
Valeria M Calcagnile
Luigi Palmieri
Daniel Ricquier
Eleonora Paradies
Pasquale Scarcia
Ferdinando Palmieri
Frédéric Bouillaud
Giuseppe Fiermonte
Institut de Biosciences et Biotechnologies · FRInstitute of Biomembranes, Bioenergetics and Molecular Biotechnologies · ITCentre National de la Recherche Scientifique · FRUniversité Paris Cité · FRUniversity of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Uncoupling protein 2 (UCP2) is involved in various physiological and pathological processes such as insulin secretion, stem cell differentiation, cancer, and aging. However, its biochemical and physiological function is still under debate. Here we show that UCP2 is a metabolite transporter that regulates substrate oxidation in mitochondria. To shed light on its biochemical role, we first studied the effects of its silencing on the mitochondrial oxidation of glucose and glutamine. Compared with wild-type, UCP2-silenced human hepatocellular carcinoma (HepG2) cells, grown in the presence of glucose, showed a higher inner mitochondrial membrane potential and ATP:ADP ratio associated with a lower lactate release. Opposite results were obtained in the presence of glutamine instead of glucose. UCP2 reconstituted in lipid vesicles catalyzed the exchange of malate, oxaloacetate, and aspartate for phosphate plus a proton from opposite sides of the membrane. The higher levels of citric acid cycle intermediates found in the mitochondria of siUCP2-HepG2 cells compared with those found in wild-type cells in addition to the transport data indicate that, by exporting C4 compounds out of mitochondria, UCP2 limits the oxidation of acetyl-CoA-producing substrates such as glucose and enhances glutaminolysis, preventing the mitochondrial accumulation of C4 metabolites derived from glutamine. Our work reveals a unique regulatory mechanism in cell bioenergetics and provokes a substantial reconsideration of the physiological and pathological functions ascribed to UCP2 based on its purported uncoupling properties.

Indexed as

CarbonCatalysisCell RespirationCitric Acid CycleEnergy MetabolismGene SilencingGlucoseGlutamineHEK293 CellsHep G2 CellsHumansIon ChannelsLiposomesMembrane Potential, MitochondrialMitochondriaMitochondrial ProteinsCarbonGlucoseGlutamineIon ChannelsLiposomesMitochondrial ProteinsOxaloacetic AcidOxygenPhosphatesUCP2 protein, humanUncoupling Protein 2diabetesglucose and glutamine metabolismmetabolic reprogrammingmitochondrial carrierWarburg effect

Identifiers

PMID24395786
PMCPMC3903233
OpenAlexW1988627015

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.